Data from multiple sources - Curated by Toby Galbraith - Last updated 06 June 2017

Latest news articles

Added 2 years ago Drug news

Pivotal trial data on APPY1 Test for Appendicitis-Venaxis

Venaxis's pivotal APPY1 Test clinical trial data for acute Appendicitis were presented at the American College of Emergency Physicians Scientific...

Added 3 years ago Drug news

Venaxis files APPY1 test for Appendicitis with FDA - Venaxis

Venaxis has announced that it has filed a 510(k) premarket submission with the FDA for the APPY1 Test, a rapid,...

Added 3 years ago Drug news

Positive topline results for APPY1 Test for Appendicitis - Venaxis

Venaxis has announced positive top-line results from its pivotal US study of its CE Marked APPY1 Test, a rapid, multiple...

Search all news articles for Appendicitis

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Chronic Spontaneous Urticaria (CSU)

Use our patient case studies to discover how experts diagnose and treat chronic spontaneous urticaria

+ 3 more

Visit Chronic Spontaneous Urticaria (CSU)


Learn about the complex factors influencing development of obesity.

Visit Obesity

Journal articles

Ceftazidime/avibactam: a novel cephalosporin/nonbeta-lactam beta-lactamase inhibitor for the treatment of complicated urinary tract infections and complicated intra-abdominal infections.

There has been greater interest in developing additional antimicrobial agents due to the increasing health care costs and resistance resulting from bacterial pathogens to currently available treatment options.

Added 5 months ago

Poor Sensitivity of a Modified Alvarado Score in Adults With Suspected Appendicitis

Study objective: A clinical decision rule that identifies patients at low risk for appendicitis may reduce the reliance on computed...

Added 4 years ago

Search all journal articles for Appendicitis